These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 27323649)

  • 21. Past-Year HIV Testing, Current Antiretroviral Therapy Use, and Participation in Services for People Who Inject Drugs.
    Sokale I; Wilkerson J; Wermuth P; Atem F; Burnett J; Wejnert C; Khuwaja S; Troisi C;
    AIDS Behav; 2024 Aug; 28(8):2793-2803. PubMed ID: 38822083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiretroviral Therapy Use Among HIV-Infected People Who Inject Drugs-20 Cities, United States, 2009-2015.
    Hoots BE; Finlayson TJ; Broz D; Paz-Bailey G;
    J Acquir Immune Defic Syndr; 2017 Jul; 75 Suppl 3(Suppl 3):S392-S396. PubMed ID: 28604444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated HIV testing, prevention, and treatment intervention for key populations in India: a cluster-randomised trial.
    Solomon SS; Solomon S; McFall AM; Srikrishnan AK; Anand S; Verma V; Vasudevan CK; Balakrishnan P; Ogburn EL; Moulton LH; Kumar MS; Sachdeva KS; Laeyendecker O; Celentano DD; Lucas GM; Mehta SH;
    Lancet HIV; 2019 May; 6(5):e283-e296. PubMed ID: 30952565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV prevention cascades for injection and sexual risk behaviors among HIV-negative people who inject drug in Iran.
    Gangi MF; Karamouzian M; Nedjat S; Rahimi-Movaghar A; Yazdani K; Shokoohi M; Mirzazadeh A
    Int J Drug Policy; 2020 Oct; 84():102868. PubMed ID: 32717706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing risk environments for HIV among people who inject drugs from three cities in Northern Mexico.
    Ospina-Escobar A; Magis-Rodríguez C; Juárez F; Werb D; Bautista Arredondo S; Carreón R; Ramos ME; Strathdee S
    Harm Reduct J; 2018 May; 15(1):27. PubMed ID: 29776368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Healthcare Access and Utilization Among Persons Who Inject Drugs in Medicaid Expansion and Nonexpansion States: 22 United States Cities, 2018.
    Lewis R; Baugher AR; Finlayson T; Wejnert C; Sionean C;
    J Infect Dis; 2020 Sep; 222(Suppl 5):S420-S428. PubMed ID: 32877551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Impact of Syringe Services Program Policy on Risk Behaviors Among Persons Who Inject Drugs in 3 US Cities, 2005-2015.
    Nassau T; Al-Tayyib A; Robinson WT; Shinefeld J; Brady KA
    Public Health Rep; 2020; 135(1_suppl):138S-148S. PubMed ID: 32735193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys.
    Handanagic S; Bozicevic I; Civljak M; Dominkovic Z; Sevic S; Barbaric J; Nemeth Blazic T; Dakovic Rode O; Begovac J
    Int J Drug Policy; 2016 Jun; 32():57-63. PubMed ID: 27160504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incarceration, Sexual Risk-Related Behaviors, and HIV Infection Among Women at Increased Risk of HIV Infection, 20 United States Cities.
    Wise A; Finlayson T; Nerlander L; Sionean C; Paz-Bailey G;
    J Acquir Immune Defic Syndr; 2017 Jul; 75 Suppl 3():S261-S267. PubMed ID: 28604426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV Testing and awareness of HIV status among people who inject drugs in greater Kuala Lumpur, Malaysia.
    Bazazi AR; Vijay A; Crawford FW; Heimer R; Kamarulzaman A; Altice FL
    AIDS Care; 2018 Jan; 30(1):59-64. PubMed ID: 28803503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuing Low Awareness and Use of Pre-exposure Prophylaxis (PrEP) for HIV among People Who Inject Drugs (PWID), San Francisco, 2022.
    Suprasert B; Tate M; Reagan D; Ruiz R; Gao K; McNaughton K; Miller K; Marr A; Taylor KD; Wilson EC; McFarland W
    AIDS Behav; 2024 Jun; 28(6):2089-2100. PubMed ID: 38526638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV prevalence and risk behaviors among people who inject drugs in two serial cross-sectional respondent-driven sampling surveys, Zanzibar 2007 and 2012.
    Matiko E; Khatib A; Khalid F; Welty S; Said C; Ali A; Othman A; Haji S; Kibona M; Kim E; Broz D; Dahoma M
    AIDS Behav; 2015 Feb; 19 Suppl 1(Suppl 1):S36-45. PubMed ID: 25399032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual HIV risk and vulnerabilities among people who inject drugs in Iran: Findings from a nationwide study in 2020.
    Mehmandoost S; Khezri M; Aghaali N; Shokoohi M; Haghdoost AA; Tavakoli F; Sharifi H; Karamouzian M
    Harm Reduct J; 2024 Oct; 21(1):187. PubMed ID: 39425102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distance matters: The association of proximity to syringe services programs with sharing of syringes and injecting equipment - 17 U.S. cities, 2015.
    Whiteman A; Burnett J; Handanagic S; Wejnert C; Broz D;
    Int J Drug Policy; 2020 Nov; 85():102923. PubMed ID: 32920424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.
    Kim NJ; Jin H; McFarland W; Raymond HF
    Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Immunodeficiency Virus Testing, Diagnosis, Linkage to Care, and Prevention Services Among Persons Who Inject Drugs, United States, 2012-2017.
    Rao S; Song W; Mulatu MS; Seena E; Essuon A; Heitgerd J
    J Infect Dis; 2020 Sep; 222(Suppl 5):S268-S277. PubMed ID: 32877556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serious Mental Illness Among Young People Who Inject Drugs: An Assessment of Injection Risks and Healthcare Use.
    Adams M; Sionean C; Broz D; Lewis R; Wejnert C;
    J Infect Dis; 2020 Sep; 222(Suppl 5):S401-S409. PubMed ID: 32877554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of hepatitis C virus in young people who inject drugs in four Colombian cities: A cross-sectional study using Respondent Driven Sampling.
    Toro-Tobón D; Berbesi-Fernandez D; Mateu-Gelabert P; Segura-Cardona ÁM; Montoya-Vélez LP
    Int J Drug Policy; 2018 Oct; 60():56-64. PubMed ID: 30107313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Awareness and willingness to use HIV self-testing among people who inject drugs in Iran.
    Khezri M; Goldmann E; Tavakoli F; Karamouzian M; Shokoohi M; Mehmandoost S; Ghalekhani N; Haghdoost AA; Des Jarlais D; Mirzazadeh A; Sharifi H
    Harm Reduct J; 2023 Oct; 20(1):145. PubMed ID: 37805505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.
    McFall AM; Solomon SS; Lucas GM; Celentano DD; Srikrishnan AK; Kumar MS; Mehta SH
    Addiction; 2017 Aug; 112(8):1480-1487. PubMed ID: 28317210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.